Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 217-224

  Kim, Hee Seung ^a   Kim, Ju Yeong ^a   Park, Noh Hyun ^a   Kim, Kidong ^b   Chung, Hyun Hoon ^a   Kim, Yong Beom ^c   Kim, Jae Weon ^a   Kim, Hak Jae ^a   Song, Yong Sang ^a,d   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

FIGO stage IB1 IIA cervical cancer; Neoadjuvant chemotherapy before surgery; Primary surgical treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LYMPH VESSEL; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER; ADJUVANT THERAPY; COMPARATIVE STUDY; HYSTERECTOMY; LYMPH NODE DISSECTION; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; RISK FACTORS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 77957756056     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.06.017     Document Type: Article

References (22)

1. WHO. World Health Organization Report: Comprehensive Cervical Cancer Control: a Guide to Essential Practice:.World Health organization Web site; 2006. Available at: http://www.who.int/reproductive-health/publications/ cervical-cancer-gep/index.htm. Accessed on May, 2010.
2. K. Kim, and S.Y. Ryu Major clinical research advances in gynecologic cancer 2009 J Gynecol Oncol 20 2009 203 209
3. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
4. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs 3rd Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
5. J.E. Sardi, G.R. di Paola, A. Cachau, O.C. Ortiz, C. Sananes, and A. Giaroli A possible new trend in the management of the carcinoma of the cervix uteri Gynecol Oncol 25 1986 139 149
6. D.S. Kim, H. Moon, K.T. Kim, Y.Y. Hwang, S.H. Cho, and S.R. Kim Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor Gynecol Oncol 33 1989 225 230
7. A. Buda, R. Fossati, N. Colombo, F. Fei, I. Floriani, and D. Geuli Alletti Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study J Clin Oncol 23 2005 4137 4145
8. F. Leborgne, J.H. Leborgne, R. Doldan, E. Zubizarreta, B. Ortega, and J. Maisonneuve Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial Int J Radiat Oncol Biol Phys 37 1997 343 350
9. P.L. Benedetti-Panici, M.A. Zullo, L. Muzii, N. Manci, F. Bellati, and F. Plotti The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer Eur J Gynaecol Oncol 24 2003 467 470
10. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials Eur J Cancer 39 2003 2470 2486
11. L. Rydzewska, J. Tierney, C.L. Vale, and P.R. Symonds Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev 2010 CD007406
12. U. Napolitano, F. Imperato, B. Mossa, M.L. Framarino, R. Marziani, and L. Marzetti The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial Eur J Gynaecol Oncol 24 2003 51 59
13. N. Katsumata, H. Yoshikawa, T. Hirakawa, T. Saito, K. Kuzuya, and T. Fujii Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I/II cervical cancer (JCOG 0102) Proceedings of the American Society of Clinical Oncology 24 No 18S 2006 abs. 5013
14. H. Chen, C. Liang, L. Zhang, S. Huang, and X. Wu Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study Gynecol Oncol 110 2008 308 315
15. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
16. H.B. Cai, H.Z. Chen, and H.H. Yin Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer J Obstet Gynaecol Res 32 2006 315 323
17. J.E. Sardi, A. Giaroli, C. Sananes, M. Ferreira, A. Soderini, and A. Bermudez Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol Oncol 67 1997 61 69
18. G.L. Eddy, B.N. Bundy, W.T. Creasman, N.M. Spirtos, R.S. Mannel, and E. Hannigan Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group Gynecol Oncol 106 2007 362 369
19. S. Kang, M.H. Kim, I.A. Park, J.W. Kim, N.H. Park, and D. Kang Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix Cancer Lett 237 2006 305 311
20. G. Ferrandina, L. Lauriola, M.G. Distefano, G.F. Zannoni, M. Gessi, and F. Legge Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients J Clin Oncol 20 2002 973 981 (Pubitemid 34141840)
21. S.E. Namkoong, J.S. Park, J.W. Kim, S.N. Bae, G.T. Han, and J.M. Lee Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy Gynecol Oncol 59 1995 136 142
22. K. Kim, M.J. Kim, H.H. Chung, S.C. Choi, S.Y. Ryu, and J.W. Kim Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer Med Hypotheses 73 2009 1005 1007